Skip to search formSkip to main contentSkip to account menu

Silubin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Buformin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Determination of content of silubin in silybin capsule by HPLC
OBJECTIVE Determination content of silybin in silybin capsule.METHODS Column:Inertsil ODS-SP(4.6mm × 250mm,5μm);mobile phase was… 
1976
1976
[Treatment of diabetes mellitus with long-acting biguanides].
The paper discusses of the results of treatment with preparations of phenylethylbiguanide (dibotin, meltrol, dipar, dibophen… 
1974
1974
[Treatment of patients with diabetes and diabetic angiopathies of the lower extremities with butylbiguanide (Silubin retard)].
1971
1971
Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin® retard)
SummaryIn man, after oral administration of 50 mg14C-butylbiguanide, the maximum serum concentration was 26–41 µg/100 ml. The… 
1970
1970
[Effect of Silubin-retard (1-butyl-biguanide hydrochloride) on the course of influenza-virus infection in mice].
1968
1968
[Our experiences in treatment of diabetes mellitus with silubin R].
1967
1967
[Our experiences with silubin R].
1965
1965
[Use of silubin in patients with diabetes mellitus].
1965
1965
Use of silubin in patients with diabetes mellitus
1960
1960
Klinische Anwendung und Indikationsbreite des Buformin (Silubin®)1
Aplicación clínica y escala de indicación de la Buformina 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)